// App-Quantinova.ai

822 : Role of c-Myc in prostate cancer stem-like cell inhibition by sulforaphane

Researchers

Presenter

  • Su-Hyeong Kim

Principal Investigators

  • Avani R. Vyas

  • Shivendra V. Singh

Medical Centers

  • University of Pittsburgh Cancer Institute, Pittsburgh, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • cMYC

  • TNF receptor superfamily member 25

Drug/Treatment

  • Sulforaphane

  • thiocoraline

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved